Low prevalence of 'classical' microscopic colitis but evidence of microscopic inflammation in Asian Irritable Bowel Syndrome patients with diarrhoea

BMC Gastroenterology

Volumn 13, Issue 1, 2013, Pages

  Hilmi, Ida ^a   Hartono, Juanda L ^a   Pailoor, Jayalakshmi ^a   Mahadeva, Sanjiv ^a   Goh, Khean Lee ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; COLLAGENOUS COLITIS; COLON DIVERTICULOSIS; COLON POLYP; COLONOSCOPY; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HEMORRHOID; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; IRRITABLE COLON; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALAYSIAN; MALE; MICROSCOPIC COLITIS; PREVALENCE; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; BIOPSY; CASE-CONTROL STUDIES; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLON; COLONOSCOPY; DIARRHEA; FEMALE; HUMANS; MALAYSIA; MALE; MICROSCOPY; MIDDLE AGED; YOUNG ADULT;

EID: 84877807692     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-13-80     Document Type: Article

References (37)

1. Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis 2009, 41:772-780. 10.1016/j.dld.2009.07.005, 19665952.
2. Rajendra S, Alahuddin S. Prevalence of irritable bowel syndrome in a multi-ethnic Asian population. Aliment Pharmacol Ther 2004, 19:704-706. 10.1111/j.1365-2036.2004.01891.x, 15023175.
3. Tan YM, Goh KL, Muhidayah R, Ooi CL, Salem O. Prevalence of irritable bowel syndrome in young adult Malaysians: a survey among medical students. J Gastroenterol Hepatol 2003, 18:1412-1416. 10.1046/j.1440-1746.2003.03212.x, 14675271.
4. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491. 10.1053/j.gastro.2005.11.061, 16678561.
5. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther 2004, 20(Suppl 2):1-9.
6. Talley NJ. Irritable bowel syndrome. Intern Med J 2006, 36:724-728. 10.1111/j.1445-5994.2006.01217.x, 1761148, 17040359.
7. Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil 2011, 17:349-359. 10.5056/jnm.2011.17.4.349, 3228974, 22148103.
8. Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007, 132:913-920. 10.1053/j.gastro.2007.01.046, 17383420.
9. Spiller R, Campbell E. Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol 2006, 22:13-17. 10.1097/01.mog.0000194792.36466.5c, 16319671.
10. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome?. Gut 2002, 51(Suppl 1):i41-i44. 1867730, 12077063.
11. Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis 2009, 41:844-849. 10.1016/j.dld.2009.07.007, 19716778.
12. Gwee KA. Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia. J Neurogastroenterol Motil 2010, 16:30-34. 10.5056/jnm.2010.16.1.30, 2879823, 20535323.
13. Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol 2010, 1:97-105. 10.4291/wjgp.v1.i3.97, 3097950, 21607147.
14. Ford AC, Talley NJ. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol 2011, 46:421-431. 10.1007/s00535-011-0379-9, 21331765.
15. Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology 2011, 140:1155-1165. 10.1053/j.gastro.2011.02.003, 21303675.
16. Limsui D, Pardi DS, Camilleri M, Loftus EV, Kammer PP, Tremaine WJ, Sandborn WJ. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007, 13:175-181. 10.1002/ibd.20059, 17206699.
17. Carmona-Sanchez R, Carrera-Alvarez MA, Perez-Aguilar RM. Prevalence of microscopic colitis in patients with irritable bowel syndrome with diarrhea predominance. Rev Gastroenterol Mex 2011, 76:39-45.
18. Madisch A, Bethke B, Stolte M, Miehlke S. Is there an association of microscopic colitis and irritable bowel syndrome-a subgroup analysis of placebo-controlled trials. World J Gastroenterol 2005, 11:6409.
19. Baert F, Schmit A, D'Haens G, Dedeurwaerdere F, Louis E, Cabooter M, De Vos M, Fontaine F, Naegels S, Schurmans P. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002, 122:20-25. 10.1053/gast.2002.30295, 11781276.
20. Miehlke S, Heymer P, Bethke B, Bastlein E, Meier E, Bartram HP, Wilhelms G, Lehn N, Dorta G, DeLarive J. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002, 123:978-984. 10.1053/gast.2002.36042, 12360457.
21. Miehlke S, Madisch A, Bethke B, Morgner A, Kuhlisch E, Henker C, Vogel G, Andersen M, Meier E, Baretton G. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2008, 135:1510-1516. 10.1053/j.gastro.2008.07.081, 18926826.
22. Miehlke S, Madisch A, Karimi D, Wonschik S, Kuhlisch E, Beckmann R, Morgner A, Mueller R, Greinwald R, Seitz G. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 2009, 136:2092-2100. 10.1053/j.gastro.2009.02.078, 19303012.
23. Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM. Lymphocytic (" microscopic" ) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 1989, 20:18-28. 10.1016/0046-8177(89)90198-6, 2912870.
24. Falodia S, Makharia GK, Sateesh J, Deo V, Tevatia MS, Gupta SD. Spectrum of microscopic colitis in a tertiary care centre in India. Trop Gastroenterol 2007, 28:121-125.
25. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Wilson I. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002, 122:1778-1783. 10.1053/gast.2002.33579, 12055584.
26. Gwee KA, Collins SM, Read NW, Rajnakova A, Deng Y, Graham JC, McKendrick MW, Moochhala SM. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003, 52:523-526. 10.1136/gut.52.4.523, 1773606, 12631663.
27. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004, 126:693-702. 10.1053/j.gastro.2003.11.055, 14988823.
28. De Silva AP, Nandasiri SD, Hewavisenthi J, Manamperi A, Ariyasinghe MP, Dassanayake AS, Jewell DP, de Silva HJ. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting. Scand J Gastroenterol 2012, 47:619-624.
29. Quigley EM. Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?. Chin J Dig Dis 2005, 6:122-132. 10.1111/j.1443-9573.2005.00202.x, 16045602.
30. Mearin F, Perello A, Balboa A. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?]. Gastroenterol Hepatol 2009, 32:364-372. 10.1016/j.gastrohep.2008.12.007, 19442413.
31. Dorofeyev AE, Kiriyan EA, Vasilenko IV, Rassokhina OA, Elin AF. Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome. Clin Exp Gastroenterol 2011, 4:141-153. 10.1007/s12328-011-0219-8, 3132856, 21753896.
32. Hanevik K, Dizdar V, Langeland N, Eide GE, Hausken T. Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome. Aliment Pharmacol Ther 2011, 34:259-260. 10.1111/j.1365-2036.2011.04715.x, 21679211.
33. Bafutto M, Almeida JR, Leite NV, Oliveira EC, Gabriel-Neto S, Rezende-Filho J. Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine. Arq Gastroenterol 2011, 48:36-40. 10.1590/S0004-28032011000100008, 21537540.
34. Corinaldesi R, Stanghellini V, Cremon C, Gargano L, Cogliandro RF, De Giorgio R, Bartesaghi G, Canovi B, Barbara G. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther 2009, 30:245-252. 10.1111/j.1365-2036.2009.04041.x, 19438846.
35. Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, Cash BD. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol 2010, 105:859-865. 10.1038/ajg.2010.55, 2887227, 20179696.
36. Malaysia National Specialist Register [http://www.nsr.org.my/].
37. Mohamed N, Marais M, Bezuidenhout J. Microscopic colitis as a missed cause of chronic diarrhea. World J Gastroenterol 2011, 17:1996-2002. 10.3748/wjg.v17.i15.1996, 3082753, 21528078.